Aardvark Therapeutics, Inc. (AARD)
Last updated: 2026-11-19 05:59:20. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Summary
Aardvark Therapeutics, Inc. (AARD) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $0.91, with a market capitalization of $27.58M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0.91 to $16.60. This page covers its latest market performance, valuation, price trends and company information.
Key Market Data
$27.58M | |
$1.16 | |
$1.23 | |
$0.91 | |
$1.15 | |
512.63K | |
641.09K | |
-- | |
$16.60 | |
$0.91 | |
-- | |
2026-06-30 |
Aardvark Therapeutics, Inc. (AARD) Latest Closing Stock Price
Aardvark Therapeutics, Inc. (AARD) last closed at $0.91 as of 2026-11-19 01:00:00, down 20.86% ($0.24) from the previous close of $1.15.
During the latest regular trading session, AARD traded between $0.91 and $1.23, with a volume of 512.63K shares. The closing price was near the lower end and near the lower end of its 52-week range.
Aardvark Therapeutics, Inc. (AARD) 7-Day Stock Price Change
Over the past seven days, Aardvark Therapeutics, Inc. (AARD) moved from $1.35 to $0.91, representing a decline of 32.59% ($0.44).
The stock traded between $0.91 and $1.70 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 380.11 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
AARD 52-Week Price Position
Position in Range: 0.0%
AARD is currently trading at $0.91, placing it 0.0% of the way from its 52-week low of $0.91 to its 52-week high of $16.60. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
What is Aardvark Therapeutics, Inc. (AARD)?
Aardvark Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases. It is focused on on developing selective compounds, targeting Bitter Taste Receptors (TAS2Rs) for hunger-associated conditions. Its product candidate, ARD-101, is an oral gut-restricted small-molecule agonist of certain TAS2Rs expressed in the gut lumen for which have initiated a Phase 3 clinical trial for hyperphagia associated with PWS.
Aardvark Therapeutics, Inc. Information
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 28 |
| Exchange | NASDAQ |
| Company Website |
AARD News
Latest news related to Aardvark Therapeutics, Inc. and AARD stock.
- Read Full Article
- Read Full Article
Aardvark Therapeutics Says FDA Meeting Scheduled For Q1 2027 To Discuss ARD-101 Development Plan In Prader-Willi Syndrome; Expects To Resume PWS Clinical Activities In 2027
- Read Full Article
Aardvark Therapeutics Q3 EPS $(0.88) Misses $(0.77) Estimate
Aardvark Therapeutics (NASDAQ:AARD) reported quarterly losses of $(0.88) per share which missed the analyst consensus estimate of $(0.77) by 14.29 percent. This is a 17.33 percent decrease over losses of $(0.75) per
Ways to Trade AARD at MEXC
How to Buy Aardvark Therapeutics, Inc. (AARD) Stock on MEXC
Eligible investors can buy real shares of Aardvark Therapeutics, Inc. (AARD) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Frequently Asked Questions (FAQ)
1.What is Aardvark Therapeutics, Inc. (AARD) stock price today?
2.Is AARD stock going up or down today?
3.What is AARD pre-market price?
4.What is AARD after-hours price?
5.Is AARD stock trading now?
6.Where does AARD sit relative to its 52-week high and low?
7.What sector is Aardvark Therapeutics, Inc. in?
8.What is Aardvark Therapeutics, Inc.'s market capitalization and where is it listed?
9.How is AARD valued in terms of P/E ratio and EPS?
10.Does Aardvark Therapeutics, Inc. pay a dividend?
Explore More US Stocks
Compliance Disclosure and Data Source
Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to AARD, including Stocks, Tokenized Stocks, and Stock Futures.
Disclaimer
The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.
Search Stocks
AARD Stock Calculator
Estimate the value between AARD shares and USD.
AARD Shares to USD
1.00 AARD shares = 0.91 USD
Calculations are estimates based on the latest available price and are for reference only.


